Company / R&D Expense
Omada Health, Inc. R&D Expense History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$40.7M
FY2025
5-year range
$40.7M / $40.7M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#86 of 110
Health Care
What the data says
Omada Health, Inc.'s r&d expense of $41M is lower than 78% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$41M in FY2025.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 110This company $40.7M Sector average $298.2M
▼
-86.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026